Neoadjuvant clinical trial designs: Challenges of the genomic era.

Abstract

The modern era has brought huge changes in the way we approach breast cancer clinical trials. The neoadjuvant, or preoperative, approach is increasingly popular because of several advantages over traditional adjuvant trials in terms of size, speed, capacity for embedded correlative science, and design flexibility. True neoadjuvant trials test the… (More)
DOI: 10.1016/j.breast.2015.07.021

Topics

Cite this paper

@article{Carey2015NeoadjuvantCT, title={Neoadjuvant clinical trial designs: Challenges of the genomic era.}, author={Lisa A. Carey}, journal={Breast}, year={2015}, volume={24 Suppl 2}, pages={S88-90} }